1. Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
   Ozlem Sherif et al, 2024, Oncology Reports CrossRef
2. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
   Prin Sungwan et al, 2021, PeerJ CrossRef
3. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
   Gustavo A. Arias-Pinilla et al, 2021, Cancers CrossRef
4. HER2 Overexpression in Periampullary Tumors According to Anatomical and Histological Classification—A Systematic Review
   Ioan Cătălin Bodea et al, 2024, Journal of Personalized Medicine CrossRef
5. Introduction to Cell Cycle and Its Regulators
   Manzoor Ahmad Mir et al, 2023, Therapeutic potential of Cell Cycle Kinases in Breast Cancer CrossRef